Calendar Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
1.72 USD -1.71% Intraday chart for Spero Therapeutics, Inc. -0.58% +17.01%

Chart calendar Spero Therapeutics, Inc.

9d330af.5kcJ2RHuSgUIPA1dCDHBy7G43I4DopejEqCVysSG3rY.tiFRjUOaeHxADkMoRnuNqoL9vd1x187gR5jCpqjklsGwDH-pZNd_SyV1fg~6f2c7fd687d6d4750a2524942450f49f

Upcoming events on Spero Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on Spero Therapeutics, Inc.

2024-03-13 04:30 pm Q4 2023 Earnings Call
2024-03-13 04:01 pm Q4 2023 Earnings Release
2024-03-04 09:50 am TD Cowen Health Care Conference
2023-11-28 07:55 am Evercore ISI HealthCONx Conference
2023-11-13 04:30 pm Q3 2023 Earnings Call
2023-11-13 04:05 pm Q3 2023 Earnings Release
2023-11-08 08:00 am Truist Securities Healthcare Conference
2023-10-05 09:00 am Annual General Meeting
2023-09-26 04:20 pm Cantor Global Healthcare Conference - Fireside Chat
2023-09-12 11:30 am H.C. Wainwright Global Investment Conference
2023-08-10 04:30 pm Q2 2023 Earnings Call
2023-08-10 04:05 pm Q2 2023 Earnings Release
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-05-02 10:30 am H.C. Wainwright BioConnect Investor Conference
2023-04-14 European Congress of Clinical Microbiology and Infectious Diseases - Poster Session: 3b #P0245
2023-04-14 European Congress of Clinical Microbiology and Infectious Diseases - Poster Session: 3b #P0151
2023-03-30 04:30 pm Q4 2022 Earnings Call
2023-03-30 04:05 pm Q4 2022 Earnings Release
2023-03-14 04:00 pm Oppenheimer Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
18,1
18,2
-0.41%
9,33
11,1
-15.73%
18,3
19,5
-6.24%
53,5
29,0
84.79%
104
48,9
112.29%

48,2

EBITDA
Million USD
Released
Forecast
Spread
-62,5
-59,4
-5.12%
-78,4
-77,0
-1.76%
-87,3
-84,0
-3.96%
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-63,2
-58,3
-8.48%
-79,1
-79,7
0.72%
-88,0
-83,9
-4.86%
-42,2
-61,6
31.47%
21,5
-34,5
162.35%

-54,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-60,9
-55,5
-9.73%
-78,3
-77,8
-0.64%
-89,8
-83,2
-7.83%
-46,4
-56,9
18.44%
25,4
-25,9
197.95%

-51,6

Net income
Million USD
Released
Forecast
Spread
-60,9
-56,8
-7.17%
-78,8
-78,9
0.1%
-89,8
-84,3
-6.45%
-46,4
-70,4
34.08%
22,8
-33,7
167.75%

-53,7

EPS
USD
Released
Forecast
Spread
-3,35
-3,13
-6.88%
-3,52
-3,58
1.63%
-2,91
-2,89
-0.81%
-1,23
-2,12
41.98%
0,43
-0,69
162.55%

-0,94

Announcement Date16/03/2011/03/2131/03/2230/03/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
2,74
4,95
-44.57%
2,07
1,93
7.48%
1,99
1,43
39.05%
2,01
5,42
-62.97%
47,4
22,9
107.47%
2,07
1,27
63.34%
2,72
1,08
150.71%
25,5
15,0
70.2%
73,5
18,6
294.58%

21,5


0,60


21,5


4,60


13,0

EBIT
Million USD
Released
Forecast
Spread
-27,5
-23,9
-15.3%
-30,2
-29,6
-2.22%
-14,2
-29,0
50.98%
-12,0
-9,98
-20.06%
25,9
6,53
296.8%
-14,2
-17,2
17.44%
-12,9
-18,4
29.88%
3,37
-1,20
381%
50,5
-6,00
942.22%

-2,70


-24,5


-4,87


-22,8


-6,30

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-29,2
-22,5
-30.16%
-32,8
-31,3
-4.77%
-28,7
-30,7
6.71%
-11,7
-11,3
-3.41%
26,8
16,3
64.44%
-13,3
-19,2
30.89%
-11,9
-19,5
38.82%
-0,99
0,43
-333.88%
51,6
3,50
1373.69%

-3,23


-23,3


-5,38


-19,7




Net income
Million USD
Released
Forecast
Spread
-29,2
-24,2
-20.78%
-32,8
-30,3
-8.19%
-28,7
-30,4
5.54%
-11,7
-10,3
-13.79%
26,8
2,79
860.57%
-13,3
-17,2
22.86%
-11,9
-18,2
34.36%
-3,21
-1,82
-76.42%
51,2
-5,27
1072%

-2,38


-24,2


-4,62


-22,6


-6,30

EPS
USD
Released
Forecast
Spread
-0,92
-0,75
-23.08%
-1,01
-0,93
-8.6%
-0,87
-0,93
6.12%
-0,33
-0,30
-8.79%
0,93
0,04
2046.32%
-0,25
-0,33
25%
-0,23
-0,34
33.01%
-0,06
-0,03
-100%
0,96
-0,10
1060%

-0,04


-0,44


-0,08


-0,38


-0,10

Announcement Date31/03/2216/05/2210/08/2214/11/2230/03/2311/05/2310/08/2313/11/2313/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise